Double Cord Versus Haploidentical (BMT CTN 1101)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care
- Status
- UNKNOWN
- Phase
- NA
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
Music Therapy on Nausea and Pain for Autologous Stem Cell
- Status
- COMPLETED
- Phase
- NA
Providing Access to Cord Blood Units for Transplants
- Status
- WITHDRAWN
- Phase
- PHASE2
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Status
- RECRUITING
- Phase
- N/A
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Preservation of Ovarian Function After Hematopoietic Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin
- Status
- COMPLETED
- Phase
- N/A
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- Status
- COMPLETED
- Phase
- N/A
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
- Status
- TERMINATED
- Phase
- N/A